Product Description
| Brand |
Beckman Coulter |
| Sample Type |
Serum/ Plasma |
| Pack Size |
2 x 50T |
| CAT No. |
33200 |
Application
|
Tumor Marker |
Beckman Coulter Access CEA (CLIA) is a high-performance Chemiluminescent Immunoassay (CLIA) reagent designed for the quantitative determination of Carcinoembryonic Antigen (CEA) in human serum and plasma. CEA is a widely recognized tumor marker used to evaluate treatment response, monitor disease progression, and detect cancer recurrence when interpreted in conjunction with clinical findings and other diagnostic procedures. The Access CEA CLIA Reagent delivers high sensitivity, excellent specificity, rapid turnaround time, and reliable quantitative results, making it an ideal choice for hospitals, oncology centers, diagnostic laboratories, pathology laboratories, and reference laboratories.
Automated CEA detection made simpleThe BC Access CEA (CLIA) Analyzer brings effortless, reliable CEA measurement to laboratories. Its fully automatic operation streamlines workflow and enhances repeatability, making it an ideal choice for clinical environments requiring swift and precise diagnostics. By using Chemiluminescence Immunoassay technology, it ensures high sensitivity and specificity in detecting Carcinoembryonic Antigen, assisting practitioners in confident clinical decision-making.
Reliable performance with user-friendly portabilityDespite its robust capabilities, the CLIA Analyzer is designed to be portable, allowing laboratories to shift its placement as required. The unit functions best when stored between 2 and 10C, preserving the effectiveness of its advanced components. Its automatic mode minimizes handling steps, reducing user error and increasing throughput in busy lab settings.
FAQ's of BC Access CEA (CLIA):
Q: How does the BC Access CEA (CLIA) Analyzer determine Carcinoembryonic Antigen levels?
A: The analyzer utilizes Chemiluminescence Immunoassay (CLIA) technology to detect and measure CEA in blood samples, providing accurate results through an automated real-time process.
Q: What are the recommended storage conditions for the BC Access CEA (CLIA) Analyzer?
A: It should be stored at a temperature between 2 and 10 degrees Celsius to maintain optimal performance and ensure the longevity of the device.
Q: When should this analyzer be used in the laboratory setting?
A: Use the BC Access CEA (CLIA) Analyzer when you need to determine CEA levels as part of tumor marker screening, cancer diagnosis, or treatment monitoring in clinical laboratories.
Q: Where can the BC Access CEA (CLIA) Analyzer be purchased in India?
A: The device is accessible through dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers throughout India.
Q: What is the process for operating the BC Access CEA (CLIA) Analyzer?
A: The analyzer operates automatically. After sample preparation, simply load the samples and follow the on-screen prompts. The device then processes and displays real-time results without manual intervention.
Q: What are the main benefits of using the BC Access CEA (CLIA) Analyzer in the laboratory?
A: Main benefits include its portability, automatic operation, advanced CLIA technology for higher sensitivity, and real-time reporting, all of which enhance diagnostic efficiency and accuracy.